High-throughput screening: update on practices and success
- PMID: 16973922
- DOI: 10.1177/1087057106292473
High-throughput screening: update on practices and success
Abstract
High-throughput screening (HTS) has become an important part of drug discovery at most pharmaceutical and many biotechnology companies worldwide, and use of HTS technologies is expanding into new areas. Target validation, assay development, secondary screening, ADME/Tox, and lead optimization are among the areas in which there is an increasing use of HTS technologies. It is becoming fully integrated within drug discovery, both upstream and downstream, which includes increasing use of cell-based assays and high-content screening (HCS) technologies to achieve more physiologically relevant results and to find higher quality leads. In addition, HTS laboratories are continually evaluating new technologies as they struggle to increase their success rate for finding drug candidates. The material in this article is based on a 900-page HTS industry report involving 54 HTS directors representing 58 HTS laboratories and 34 suppliers.
Similar articles
-
Affinity-based screening techniques for enhancing lead discovery.Curr Opin Drug Discov Devel. 2004 Jul;7(4):411-6. Curr Opin Drug Discov Devel. 2004. PMID: 15338950 Review.
-
Novel trends in high-throughput screening.Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21. Curr Opin Pharmacol. 2009. PMID: 19775937 Review.
-
Mass spectrometric techniques for label-free high-throughput screening in drug discovery.Anal Chem. 2007 Nov 1;79(21):8207-13. doi: 10.1021/ac062421q. Epub 2007 Sep 29. Anal Chem. 2007. PMID: 17902631
-
Label-free screening assays: a strategy for finding better drug candidates.Future Med Chem. 2010 Nov;2(11):1703-16. doi: 10.4155/fmc.10.246. Future Med Chem. 2010. PMID: 21428840 Review.
-
Which aspects of HTS are empirically correlated with downstream success?Curr Opin Drug Discov Devel. 2008 May;11(3):327-37. Curr Opin Drug Discov Devel. 2008. PMID: 18428086 Review.
Cited by
-
An Evaluation of the Potential of NMR Spectroscopy and Computational Modelling Methods to Inform Biopharmaceutical Formulations.Pharmaceutics. 2018 Sep 21;10(4):165. doi: 10.3390/pharmaceutics10040165. Pharmaceutics. 2018. PMID: 30248922 Free PMC article. Review.
-
Faster, better, and cheaper: harnessing microfluidics and mass spectrometry for biotechnology.RSC Chem Biol. 2021 Jul 20;2(5):1331-1351. doi: 10.1039/d1cb00112d. eCollection 2021 Oct 7. RSC Chem Biol. 2021. PMID: 34704041 Free PMC article. Review.
-
Bigger data, collaborative tools and the future of predictive drug discovery.J Comput Aided Mol Des. 2014 Oct;28(10):997-1008. doi: 10.1007/s10822-014-9762-y. Epub 2014 Jun 19. J Comput Aided Mol Des. 2014. PMID: 24943138 Free PMC article.
-
Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library.J Chem Inf Model. 2011 Oct 24;51(10):2449-54. doi: 10.1021/ci200260t. Epub 2011 Oct 6. J Chem Inf Model. 2011. PMID: 21978256 Free PMC article.
-
Large-scale virtual screening on public cloud resources with Apache Spark.J Cheminform. 2017 Mar 6;9:15. doi: 10.1186/s13321-017-0204-4. eCollection 2017. J Cheminform. 2017. PMID: 28316653 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources